In conclusion, despite the rather extensive literature supporting CD40 as a therapeutic target in autoimmune diseases, our study shows no clinical benefit of interfering with the CD40-CD154 interaction by expression of soluble CD40 fusion proteins at the levels of expression we were able to achieve in the SG in this animal model of SS. Here, CD40 is linked to autoimmune disease.